GlassScriptPhysician profile
Ann Y Becker
NPI 1588688642
$4,339.56
in general payments reported to CMS, 2019-2025
27 companies · $528 in 2025
The $528 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $704 · 2020: $220 · 2021: $210 · 2022: $541 · 2023: $394 · 2024: $1,742 · 2025: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,421 · Travel and Lodging: $1,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,421.25 |
| Travel and Lodging | $1,243.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,542.90 | 2022-2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $462.43 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $293.87 | 2023-2025 | Gemtesa |
| Medtronic, INC. | $196.83 | 2024-2025 | Altaviva, Interstim |
| Urovant Sciences INC | $166.59 | 2021-2022 | |
| Abbvie INC. | $165.64 | 2019-2025 | Botox |
| Boston Scientific Corporation | $146.88 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Amag Pharmaceuticals, INC. | $133.94 | 2019 | |
| Procept Biorobotics Corporation | $129.90 | 2024 | Aquabeam System |
| Ethicon US, LLC | $128.46 | 2019-2023 | Dermabond Prineo, Evarrest, Echelon; Endopath |
| Bayer Healthcare Pharmaceuticals INC. | $122.07 | 2023 | |
| Janssen Biotech, INC. | $119.92 | 2019-2025 | Erleada |
| Antares Pharma, INC. | $118.26 | 2022 | |
| Calyxo, INC. | $107.07 | 2025 | Cvac Aspiration System |
| Teleflex LLC | $84.81 | 2022-2025 | Barrigel, Urolift |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $75.12 | 2019-2021 | |
| Tolmar, INC. | $65.18 | 2025 | Eligard, Jatenzo |
| Myriad Genetic Laboratories, INC. | $49.32 | 2022-2024 | Prolaris |
| Convatec INC. | $38.67 | 2023 | |
| 180 Medical, INC. | $34.83 | 2019 | |
| Ferring Pharmaceuticals INC. | $31.58 | 2019 | |
| Pfizer INC. | $29.16 | 2020-2022 | |
| Hollister Incorporated | $28.52 | 2022 | |
| Ambu INC. | $22.07 | 2024 | |
| Dentsply Ih INC. | $19.00 | 2020 | |
| Acerus Pharmaceuticals Corporation | $16.49 | 2022 | |
| Clarus Therapeutics INC. | $10.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.